CHANGE IN RATINGS
initiated at Jefferies with Hold rating. Price target starts at $10 and 2008 EPS estimates begin at $0.90.
(BBY - Get Report)
downgraded at Bear to Underperform. Slowdown in the product cycle will likely pressure margins. Company may also lose market share to discounters. Stocks is also not pricing in macro risks.
upgraded at UBS to Buy rating from Neutral. Price target jumps to $70 from $55 and 2008 EPS estimates hold at $0.14.
Salesforce.com downgraded at Goldman to Sell from Neutral based on valuation in a somewhat slower macro environment for IT and software spending. Maintained $51 price target.
upgraded at Wachovia from Market Perform to Outperform. Company has a large backlog of organic growth projects. E&P portfolio should also help uncover value.
downgraded at Deutsche Bank to a Hold rating due to growing caution on commercial auto. Target price cut to $73.
Health Management Assoc.
upgraded at Wachovia from Market Perform to Outperform. Accelerating growth, margin expansion and asset sales could drive multiple expansion. Estimates also raised.
upgraded at Morgan Stanley to Equal-weight. $52 price target. $52 price target. Company has solid near-term earnings visibility and a 3.5% dividend yield, though the late-stage pipeline remains soft.
upgraded at Bear from Peer Perform to Outperform. $52 price target. Company is approaching an inflection point for accelerating growth.